Skip to content

Modified Oscor Py Pacing Leads

by Oscor Medical Corp.

510(k) K862330

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 22 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK862330 Date8 Aug 1986ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 22 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
DTB
Device Class
Class III
Regulation
21 CFR Part 870.3680
Advisory Committee
Cardiovascular
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Modified Oscor Py Pacing Leads are classified as Permanent Pacemaker Electrodes, designed to deliver electrical stimulation to the heart. These leads facilitate cardiac rhythm management by transmitting impulses from an implanted or external pacemaker to the heart muscle, ensuring proper pacing in patients with arrhythmias or bradycardia. They are positioned within the heart chambers via transvenous insertion to maintain effective cardiac function.

These leads are supplied as reusable medical devices and are regulated under FDA 510(k) clearance (K862330) with a decision of Substantially Equivalent. They fall under product code DTB and are intended for use in cardiovascular applications. Sterility and MRI safety are not specified in the available data, and no additional details on storage or single-use versus reusable status beyond the regulatory filing are provided.

Other devices from Oscor Medical Corp.

See all devices from Oscor Medical Corp. →

Questions

AI-generated answers, 20 Sep 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • Are these pacing leads intended for single-use or can they be reused after implantation?

    The Modified Oscor Py Pacing Leads are explicitly classified as reusable medical devices in the regulatory filing. This means they are designed for repeated use in patients after proper cleaning, sterilization (if applicable), and maintenance procedures. Since they are regulated under FDA 510(k) clearance, their reuse status is confirmed through the regulatory submission process, though specific sterilization or cleaning instructions are not detailed in the provided data.

  • What types of arrhythmias or cardiac conditions are these leads primarily used to manage?

    These leads are permanent pacemaker electrodes intended for transvenous insertion within the heart chambers to deliver electrical stimulation. They are used in patients with arrhythmias or bradycardia to ensure proper cardiac rhythm management by transmitting impulses from an implanted or external pacemaker. The regulatory filing specifies their use in cardiovascular applications, but the exact arrhythmias or conditions are not listed beyond general pacing needs.

  • How are these leads supplied, and what sizes or models are available?

    The data provided does not specify exact sizes or model variations, but the Modified Oscor Py Pacing Leads are supplied as reusable devices for permanent pacemaker use. The regulatory filing lists multiple FEI numbers (e.g., 3002618605, 1028232), which may correspond to different lead configurations or variants, though no detailed specifications (e.g., length, diameter, or electrode type) are included. For precise sizing or model details, manufacturer documentation or direct inquiry to Oscor Medical Corp. would be necessary.

  • What is the regulatory pathway for these leads, and how were they cleared by the FDA?

    The Modified Oscor Py Pacing Leads were cleared through the FDA 510(k) process under Traditional Review, with a decision of Substantially Equivalent (SESE) to a predicate device. The filing date was June 19, 1986, and clearance was granted on August 8, 1986, with the product code DTB (Permanent Pacemaker Electrodes). The Cardiovascular (CV) Advisory Committee reviewed the submission, confirming their use in cardiovascular applications for pacing purposes.

  • Are there any specific storage requirements mentioned for these reusable leads?

    The provided data does not include explicit storage instructions for the Modified Oscor Py Pacing Leads. Since they are reusable, proper handling and storage (e.g., clean, dry environment, protection from contamination) would typically be required to maintain sterility and functionality. For detailed storage guidelines, refer to the manufacturer’s instructions or technical documentation from Oscor Medical Corp., as these are not specified in the regulatory filing.